Legionnaires disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:549A48.1
Who is this for?
Show terms as
19Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Legionnaires disease (also known as Legionellosis or Legion fever) is a severe form of pneumonia caused by infection with Legionella bacteria, most commonly Legionella pneumophila. It is not a genetic disorder but rather an infectious disease classified among rare conditions due to its relatively uncommon occurrence. The bacteria are typically found in freshwater environments and can proliferate in man-made water systems such as cooling towers, hot tubs, decorative fountains, and large plumbing systems. Humans become infected by inhaling aerosolized water droplets or mist contaminated with the bacteria; person-to-person transmission does not occur. The disease primarily affects the respiratory system, causing a serious and potentially life-threatening pneumonia. Key clinical features include high fever (often exceeding 40°C/104°F), chills, cough (which may be productive or dry), shortness of breath, muscle aches (myalgia), headaches, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. Neurological manifestations including confusion and altered mental status may also occur. The disease can progress to respiratory failure and multi-organ dysfunction, particularly affecting the kidneys and liver. Certain populations are at higher risk, including older adults (typically over 50 years), current or former smokers, individuals with chronic lung disease, and immunocompromised persons, including those on immunosuppressive therapy or with conditions such as diabetes or cancer. Treatment consists of antibiotic therapy, with fluoroquinolones (such as levofloxacin or moxifloxacin) and macrolides (such as azithromycin) being the preferred agents. Early initiation of appropriate antibiotic therapy significantly improves outcomes. Hospitalization is frequently required, and severe cases may necessitate intensive care support including mechanical ventilation. Even with appropriate treatment, the case fatality rate can range from approximately 5% to 10% in community-acquired cases and may be higher in nosocomial (hospital-acquired) outbreaks or among immunocompromised patients. Prevention strategies focus on proper maintenance and disinfection of water systems to minimize bacterial colonization.

Clinical phenotype terms— hover any for plain English:

Abnormal lung morphologyHP:0002088
Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Legionnaires disease.

View clinical trials →

No actively recruiting trials found for Legionnaires disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Legionnaires disease community →

Specialists

19 foundView all specialists →
SJ
Sophie Jarraud
Specialist
2 Legionnaires disease publications
CA
Camille Allam
Specialist
2 Legionnaires disease publications
HD
Hélène Sabbah-Guillaume, Director
Specialist
PI on 1 active trial
RP
Richard L Doty, PhD
BALTIMORE, MD
Specialist
PI on 2 active trials
RC
Rocio Carmona
LITTLEROCK, CA
Specialist
1 Legionnaires disease publication
NL
Noemí López-Perea
Specialist
1 Legionnaires disease publication
VG
Valeria Gaia
Specialist
1 Legionnaires disease publication
CM
Carolina Manzur-Barbur
Specialist
1 Legionnaires disease publication
JC
Jordi Carratalà
Specialist
1 Legionnaires disease publication
DG
Diana Gómez-Barroso
Specialist
1 Legionnaires disease publication
DP
Despina Pampaka
Specialist
1 Legionnaires disease publication
CE
Chris Edens
Specialist
3 Legionnaires disease publications
AB
Albert E Barskey
Specialist
2 Legionnaires disease publications
JS
Jessica C Smith
Specialist
2 Legionnaires disease publications
DV
Diego Viasus
Specialist
1 Legionnaires disease publication
MM
Marco Moretti, MD
Specialist
PI on 1 active trial
AM
ALBERT IRUTHIARAJ L ANTHONY, MBBS
Specialist
PI on 1 active trial
JR
Jordi Rello
Specialist
1 Legionnaires disease publication
AR
Alfonsina Ruiz-Spinelli
Specialist
1 Legionnaires disease publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Legionnaires disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Legionnaires diseaseForum →

No community posts yet. Be the first to share your experience with Legionnaires disease.

Start the conversation →

Latest news about Legionnaires disease

No recent news articles for Legionnaires disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Legionnaires disease

What is Legionnaires disease?

Legionnaires disease (also known as Legionellosis or Legion fever) is a severe form of pneumonia caused by infection with Legionella bacteria, most commonly Legionella pneumophila. It is not a genetic disorder but rather an infectious disease classified among rare conditions due to its relatively uncommon occurrence. The bacteria are typically found in freshwater environments and can proliferate in man-made water systems such as cooling towers, hot tubs, decorative fountains, and large plumbing systems. Humans become infected by inhaling aerosolized water droplets or mist contaminated with the

At what age does Legionnaires disease typically begin?

Typical onset of Legionnaires disease is adult. Age of onset can vary across affected individuals.

Which specialists treat Legionnaires disease?

19 specialists and care centers treating Legionnaires disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.